“…Research on ethnic group pharmacogenetics in Latin America is still scarce ( Sosa-Macías et al, 2016 ; Leitão et al, 2020 ), but there is evidence of pharmacogenetic differences ( Suarez-Kurtz and Parra, 2018 ). For example, Mestizo populations are not considered a unique group for these types of studies, since miscegenation varies in each Latin American country ( Botton et al, 2019 ).The COVID-19 pandemic has shown us that data and access to pharmacogenetic information are required for making clinical decisions in a prioritized and sometimes urgent ways.…”